New heart procedure tested for safety and success
NCT ID NCT06801392
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well and how safely a new catheter (Varipulse) works for treating a type of irregular heartbeat called atrial fibrillation. About 50 adults with this condition will receive the procedure. Researchers will check if the treatment successfully blocks faulty electrical signals and monitor for any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Kralovske Vinohrady
RECRUITINGPrague, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- Blood fat clues could flag hidden heart rhythm risk
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Smartphone light sensor may spot when an irregular heartbeat fixes itself
- Can a Wrist-Worn sensor outsmart atrial fibrillation?